Effects of fluoxetine on the development of lung metastases induced by operative stress in rats

Life Sciences

Volumn 63, Issue 2, 1998, Pages PL31-PL38

  Freire Garabal, Manuel ^a   Núňez, María J ^a   Pereiro, Dolores ^a   Riveiro, Pilar ^a   Losada, Concepción ^a   Fernández Rial, José C ^a   García Iglesias, Elisardo ^a   Prizmic, Javier ^b   Mayán, José M ^a   Rey Méndez, Manuel ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b University John F Kennedy   (Argentina)

Author keywords

Cancer; Fluoxetine; Stress; Surgery; Walker rat carcinoma

Indexed keywords

FLUOXETINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LAPAROTOMY; LUNG METASTASIS; MALE; NONHUMAN; RAT; SURGICAL STRESS; SURVIVAL; WALKER CARCINOMA;

EID: 17144458587     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(98)00253-7     Document Type: Article

References (62)

1. 1. L. QUI-SHI and Y. GUI-ZHEN, Immunol. Invest. 15 419-430 (1986).
2. 2. E.W. BARNES, A. FARMER, W.J. PENHALA, W.J. IRVINE, P. ROSCOE and N.W. HORNE, Cancer 36 187-193 (1975).
3. 3. A.B. COSINI, F.H. BRUNSTTETER, W.T. KEMMMERER and B.N. MILLER, Arch. Surg. 107 531-535 (1973).
4. 4. P.J. GUILLOW, T.G. BRENNER and G.R. GEILES, Br. J. Surg. 60 745-749 (1973).
5. 5. T. OKIMURA, M. OGAWA and T. YAMAUCHI, Jpn. J. Pharmacol. 41 229-235 (1986).
6. 6. A. JUSTICE, Psychol. Bull. 98 108-138 (1985).
7. 7. H.A.S. VAN DEN BRENK, M.G. STONE, H. KELLY and C. SHARPINGTON, Br. J. Cancer, 33, 60-78 (1976).
8. 8. M. FREIRE-GARABAL, M.J. NÚÑEZ, C. LOSADA, D. PEREIRO, M.P. RIVEIRO, E. GONZÁLEZ-PATIÑO, J.M. MAYÁN and M. REY-MÉNDEZ, Life Sci. 60 403-413 (1997).
9. 9. J.M. HANSBROUGH, R.L. ZAPATA-SIRVENT, E.J. BARTLE, J.K. ANDERSON, L. ELLIOTT, M.A. MANSOUR and W.H. CARTER, Anesthesiology 63 267-273 (1985).
10. 10. T. HATTORI, Y. HAMAI, H. IKEDA, T. HARADA and T. IKEDA, GANN, 69 401-406 (1978).
11. 11. R. ADER and S.B. FRIEDMAN, J. Comp. Psychol. 59 361-364 (1965).
12. 12. P. BUINAUSKAS, G.O. MCDONALD and W.H. COLE, Ann. Surg. 148 642-648 (1958).
13. 13. R. ADER, D. FELTEN and N. COHEN. Annu. Rev. Pharmacol. Toxicol. 30 561-602 (1990).
14. 14. H. ZIMEL and A. ZIMEL, Rev. Roum. Endocrinol. 11 213-220 (1974).
15. 15. M. BIONDI and D. KOTZALIDIS J. Clin. Lab. Analysis 4 22-38 (1990).
16. 16. M. FREIRE-GARABAL, M.J. NÚÑEZ, J.L. BALBOA, J.C. FERNÁNDEZ-RIAL and M. REY-MÉNDEZ, Pharmacol. Biochem. Behav. 51 821-825 (1995).
17. 17. V. RILEY, Science 189 465-467 (1975).
18. 18. V. RILEY, Science, 212 1100-1109 (1981).
19. 19. M. FREIRE-GARABAL, A. BELMONTE, F. ORALLO and M.J. NÚÑEZ, Cancer Lett. 58 183-187 (1991).
20. 20. Z. STEPLEWSKI, P.R. GOLDMAN, H. EHYA, C. POROPATICH and J.M. SMITH, Cancer Res. 45 5128-5130 (1985).
21. 21. S. BEN-ELIYAHU, R. YIRMIYA, Y. SHAVIT and J.C. LIEBESKIND, Behav. Neurosci. 104 235-238 (1990).
22. 22. J. IRVIN and S. LIVNAT, Prog. Neuropsychopharmacol. Biol. Psychiatry 11 137-143 (1987).
23. 23. A.A. MONJAN and M.I. COLLECTOR, Science 15 307-308 (1987).
24. 24. J.E. MORLEY, N.E. KAY, G.F. SOLOMON and N.P. PLOTNIKOFF, Life Sci. 41 527-544 (1987).
25. 25. Y. SHAVIT, G.W. TERMAN, F.C. MARTIN, J.W. LEWIS, J.C. LIEBESKIND and R.P. GALE, J. Immunol. 135 834-837 (1985).
26. 26. S.E. KELLER, S.J. SCHLEIFER, M.A. CAMERINO, J.A. FALINI, J. HALPERIN and M. STEIN, Psychosom. Med. 46 286-293 (1984).
27. 27. J.E. BLALOCK, Int. J. Neurosci. 51 363-364 (1990).
28. 28. K. BULLOCK, The neuro-immune-endocrine connection, C.W. Cotman, R.E. Brinton, A. Galaburda, and B. McEwen B. (eds), 33-47, Raven Press, New York (1987).
29. 29. J.E. BLALOCK, K.L. BOST and E.M. SMITH, J. Neuroimmunol. 10 31-40 (1985).
30. 30. D.A. WEIGENT and J.E. BLALOCK, J. Neuroimmunol. 29 1-13 (1990).
31. 31. O.S. SURMAN, Psychosomatics 34 139-143 (1993).
32. 32. J.G. RABKIN, R. RABKIN and G. WAGNER, J. Clin. Psychiatry 55 92-97 (1994).
33. 33. M. MAES, H.Y. MELTZER, E. BOSMANS, R. BERGMANS, E. VANDOOLAEGHE, R. RANJAN and R. DESNYDER, J. Affect. Disord. 34 301-309 (1995).
34. 34. M.B. BERKELEY, S. DAUSSIN, M.C. HERNÁNDEZ and B.M. BAYER, Immunopharmacol. Immunotoxicol. 16 165-178 (1994).
35. 35. J. MARX, Science 257 22-23 (1992).
36. 36. S. NEMECEK, Sci. Am. 271 22-23 (1994).
37. 37. J.L. SHUSTER, T.A. STERN and D.B. GREENBERG, Oncology 6 45-50 (1992).
38. 38. A.B. STEINGART and M. COTTERCHIO, J. Clin. Epidemiol. 48 1407-1412 (1995).
39. 39. A.N. CROWSON and C.M. MAGRO. Arch. Dermatol. 131 925-929 (1995).
40. 40. L.J. BRANDES, R.J. ARRON, R.P. BOGDANOVIC, J. TONG, C.L. ZABORNIAK, G.R. HOGG, R.C. WARRINGTON, W. FANG and F.S. LABELLA, Cancer Res. 52 3796-3800 (1992).
41. 41. M. ABDUL, C.J. LOGOTHETIS and N.M. HOOSEIN, J. Urol. 154 247-250 (1995).
42. 42. R.A. BENDELE, E.R. ADAMS, W.P. HUFFMAN, C.L. GRIES and D.M. MORTON, Cancer Res. 52 6931-6935 (1992).
43. 43. P. STARK, R.W. FULLER and D.T. WONG, J. Clin. Psychiatry 46 7-13 (1985).
44. 44. J.C. JACKSON, R.J. CROSS, R.F. WALKER, W.R. MARKESBERY, W.H. BROOKS and T.L. ROSZMAN, Immunology 54 505-512 (1985).
45. 45. J.C. AMEISEN, R. MEADE and P.W. ASKENASE, J. Immunol. 142 3171-3179 (1989).
46. 46. Z. STEPLEWSKI and W.H. VOGEL, Neurosci. Lett. 62 277-282 (1985).
47. 47. E.M. STERNBERG, H.J. WEDNER, M.K. LEUNG and C.W. PARKER, J. Immunol. 138 4360-4365 (1987).
48. 48. I. PAEGELOW, H. WERNER, M. HAGEN, U. WARTNER and P. LANGE, Int. J. Immunopharmacol. 7 889-896 (1985).
49. 49. K. HELLSTRAND and S. HERMODSSON, J. Immunol. 139 869-875 (1987).
50. 50. K. HELLSTRAND and S. HERMODSSON, Cell Immunol. 127 199-214 (1990).
51. 51. B.A. FARAJ, Z.L. OLKOWSKI and R.T. JACKSON, Pharmacology 48 320-327 (1994).
52. 52. M. BIANCHI, P. SACERDOTE and A.E. PANERAI, Eur. J. Pharmacol. 363 81-84 (1994).
53. 53. R.W. FULLER and H.D. SNODDY, Neuroendocrinology. 31 96-100 (1980).
54. 54. F. PETRAGLIA, F. FACCHINETTI, E. MARTIGNONI, G. NAPPI, A. VOLPE and A.R. GENAZZANI. J. Clin. Endocrinol. Metab. 59 1138-1142 (1984).
55. 55. D.M. GIBBS and W. VALE. Brain Res. 280 176-179 (1983).
56. 56. H.N. BHARGAVA, Stress and Immunity, N. Plotnikoff, A. Murgo, R. Faith, and J. Wybran (eds), 329-342, CRC Press, Boca Raton, Florida (1991).
57. 57. E.M. SMITH, D.V. HARBOUR, T.K. HUGHES, T. KENT, M.J. EBAUGH, A. JAZAYERI and W.J. MEYER, Stress and Immunity, N. Plotnikoff, A. Murgo, R. Faith and J. Wybran (eds), 353-479, CRC Press, Boca Raton, Florida (1991).
58. 58. T.L. GARTHWAITE and T.C. HAGEN, Neuroendocrinology 29 215-20 (1979).
59. 59. W.W. MORGAN and D.C. HERBERT, Endocrinology 103 1016-1022 (1978).
60. 60. J.H. THAKORE and T.G. DINAN. Am. J. Psychiatry 152 616-618 (1995).
61. 61. J.W. HOLADAY, H.U. BRYANT, J.R. KENNER and E.W. BERNTON. Prog. Neuroendocrinimmunol. 1 6-10 (1988).
62. 62. K.W. KELLEY and R. DANTZER, Stress and Immunity, N. Plotnikoff, A. Murgo, R. Faith, and J. Wybran (eds), 433-452, CRC Press, Boca Raton, Florida (1991).